Continuous Renal Replacement Therapy Market Report 2024-2033: Share, Trends, Demand, Overview

The continuous renal replacement therapy global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Continuous Renal Replacement Therapy Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size – The continuous renal replacement therapy market size has grown rapidly in recent years. It will grow from $1.41 billion in 2023 to $1.57 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increased demand for advanced CRRT devices, an increase in the prevalence of incidence of acute kidney injury, a rise in the number of medical applications, a high prevalence of co-morbidities, and continuous research and development.

The continuous renal replacement therapy market size is expected to see rapid growth in the next few years. It will grow to $2.38 billion in 2028 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to increasing incidences of chronic kidney diseases, rising prevalence of diabetes, a growing number of ICU admissions, rising investments in healthcare infrastructure, and expanding applications in pediatric care. Major trends in the forecast period include rapid advancements, launches of new technologies, technological advancements, product innovation, and technologically advanced CRRT products.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/continuous-renal-replacement-therapy-global-market-report

Scope Of Continuous Renal Replacement Therapy MarketThe Business Research Company’s reports encompass a wide range of information, including:

Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
Drivers: Examination of the key factors propelling market growth.

Trends: Identification of emerging trends and patterns shaping the market landscape.
Key Segments: Breakdown of the market into its primary segments and their respective performance.
Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
Macro Economic Factors: Assessment of broader economic elements impacting the market.

Continuous Renal Replacement Therapy Market Overview

Market Drivers -The increasing incidence of chronic kidney diseases is expected to propel the growth of the continuous renal replacement therapy market going forward. Chronic kidney disease (CKD) is a long-term condition where the kidneys progressively lose function over time, leading to impaired filtration of waste products from the blood. The rising incidence of chronic kidney diseases is influenced by lifestyle changes, aging populations, and increasing rates of diabetes and hypertension. Continuous renal replacement therapy is utilized in chronic kidney disease for acute exacerbations or complications to manage fluid balance and continuously remove metabolic waste products. For instance, in July 2022, according to the Centers for Disease Control and Prevention, a US-based national public health agency, around 15%, or 37 million people in the US, were affected by kidney disease. Furthermore, according to a report from the Australian Institute of Health and Welfare, an Australia-based government agency, the prevalence of kidney replacement therapy in 2020 was 95.4 (per 100,000 population), up from 94 (per 100,000 population) in 2019. Therefore, the increasing incidence of chronic kidney diseases is driving the growth of the continuous renal replacement therapy market.

Market Trends – Major companies operating in the continuous renal replacement therapy market are developing technologically advanced products, such as continuous renal replacement therapy (CRRT) platforms, to better serve customers with advanced features. Continuous Renal Replacement Therapy (CRRT) platforms refer to the systems and technologies used in the delivery of CRRT, a form of dialysis primarily prescribed to critically ill patients who cannot tolerate regular hemodialysis. For instance, in May 2021, Baxter International Inc., a US-based healthcare company, launched the Prismax 2 platform. It is designed to simplify the delivery of continuous renal replacement therapy (CRRT) and other organ support therapies. It offers hospitals the flexibility needed to address the unique demands of the intensive care unit (ICU). The Prismax 2 system includes new solutions from the company’s TrueVue digital health portfolio and features the Prismalung+ blood-gas exchanger, which provides extracorporeal carbon dioxide removal (ECCO2R) therapy to aid in the management of acute respiratory dysfunction.

The continuous renal replacement therapy market covered in this report is segmented –

1) By Product: System, Consumables

2) By Therapy: Renal, Non-Renal

3) By Modality: Slow Continuous Ultra-Filtration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), Continuous Venovenous Hemodiafiltration (CVVHDF)

4) By Age Group: Adults, Pediatrics Or Neonates

5) By End-Users: Hospitals, Ambulatory Care, Homecar

Get an inside scoop of the continuous renal replacement therapy market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15777&type=smp

Regional Insights – North America was the largest region in the continuous renal replacement therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous renal replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Key Companies – Major companies operating in the continuous renal replacement therapy market are Medtronic Plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, NxStage Medical Inc., Hillrom Holdings Inc., Gambro AB, JMS Co. Ltd., Quanta Dialysis Technologies Ltd., Bellco S.r.l., Ningbo Tianyi Medical Devices Co. Ltd., Cytosorbents Corporation, Kawasumi Laboratories Inc., Medica S.p.A., Infomed SA , Medites Pharma Spol. S.R.O, Nikkiso Co. Ltd., Anjue Medical Equipment Co. Ltd., Medcomp Systems Ltd.

Table of Contents

Executive Summary
Continuous Renal Replacement Therapy Market Report Structure
Continuous Renal Replacement Therapy Market Trends And Strategies
Continuous Renal Replacement Therapy Market – Macro Economic Scenario
Continuous Renal Replacement Therapy Market Size And Growth

…..

Continuous Renal Replacement Therapy Market Competitor Landscape And Company Profiles
Key Mergers And Acquisitions
Future Outlook and Potential Analysis
Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/